Clinical Trial Update: PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

View source ↗

Summary

An observational study in treatment-naïve chronic hepatitis C patients identifies predictors of response to pegylated interferon therapy (Pegasys or peginterfer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2016-05-09